Dr. Claudia Rössig
Professor
Pediatric and Adolescent Medicine - Pediatric Hematology
University of Munster
Germany
Biography
School education-Grundschule Giesen, Lower Saxony, 1975-1979, Gymnasium of the Marienschule Hildesheim, 1979-1988, Graduation in 1988 University of Lübeck, Medical Faculty, 1988-1995 State sex: 23.10.1995 Doctoral thesis "Examination of the central and peripheral auditory pathway as well as speech development in children with alcohol embryopathy" Medical Faculty, University of Lübeck, 7.12.1995, "Magna cum laude" U.S.American Certificate of the Educational Commission for Foreign Graduate Medical Graduate (ECFMG), Philadelphia, USA, March 1998 General Medical Council Specialist registration as Paediatrician London, UK, 2006.
Research Interest
Pediatrics and Adolescent Medicine
Publications
-
Möricke A, Zimmermann M, Valsecchi MG, Stanulla M, Rössig C, et al. (2016) Dexamethasone vs prednisone in induction treatment of pediatric ALL: results of the randomized trial AIEOP-BFM ALL 2000. Blood 127: 2101-2112.
-
Kailayangiri S, Altvater B, Spurny C, Jamitzky S, Rossig C, et al. (2017) Targeting Ewing sarcoma with activated and GD2-specific chimeric antigen receptor-engineered human NK cells induces upregulation of immune-inhibitory HLA-G. Oncoimmunology 6: e1250050.
-
Rossig C, Pule M, Altvater B, Saiagh S, Wright G, et al. (2017) Vaccination to improve the persistence of CD19CAR gene-modified T cells in relapsed pediatric acute lymphoblastic leukemia. Leukemia 31: 1087-1095.
-
Tanaka M, Tashiro H, Omer B, Lapteva N, Rossig C, et al. (2017) Vaccination Targeting Native Receptors to Enhance the Function and Proliferation of Chimeric Antigen Receptor (CAR)-Modified T Cells. Clin Cancer Res.
-
Albring JC, Inselmann S, Sauer T, Schliemann C, Rössig C, et al. (2017) PD-1 checkpoint blockade in patients with relapsed AML after allogeneic stem cell transplantation. Bone Marrow Transplant 52: 317-320.
